Biocon’s diabetes drug available under PBS in Australia
Bengaluru (IANS) Biotech major Biocon said here on Thursday its insulin Glargine Semglee, co-developed with Mylan to treat diabetes, was available in Australia under the pharmaceutical benefits scheme (PBS). “As a basal insulin analogue, Semglee is given once a day to … read more










